Skip to content

Ocata Therapeutics, Inc.: 10-K filed 2015-03-16

What Ocata Therapeutics, Inc. reported in its annual report filed 2015-03-16 (fiscal FY 2014): 35 published measures, 114 facts as tagged in accession 0001019687-15-000981.

This filing

Form
10-K (annual report)
Filed
2015-03-16
Fiscal period
fiscal FY 2014
Accession
0001019687-15-000981 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Ocata Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-315,737,484USD
At 2013-12-313,907,919USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-318,473,029USD
At 2013-12-3126,441,529USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-31-2,735,545USD
At 2013-12-31-22,533,610USD
At 2012-12-31-23,144,214USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-314,424,374USD
At 2013-12-311,743,485USD
At 2012-12-317,241,852USD
At 2011-12-3113,103,007USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-6,824,735USD92
2014-01-01 to 2014-12-31-34,748,945USD365
2014-07-01 to 2014-09-30-3,716,460USD92
2014-04-01 to 2014-06-30-15,517,976USD91
2014-01-01 to 2014-03-31-8,689,774USD90
2013-10-01 to 2013-12-31-11,871,820USD92
2013-01-01 to 2013-12-31-31,022,248USD365
2013-07-01 to 2013-09-30-5,745,735USD92
2013-04-01 to 2013-06-30-6,894,056USD91
2013-01-01 to 2013-03-31-6,510,637USD90
2012-01-01 to 2012-12-31-34,584,115USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-31263,375USD365
2013-01-01 to 2013-12-31671,827USD365
2012-01-01 to 2012-12-3196,260USD366

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-10-01 to 2014-12-3139,471USD92
2014-07-01 to 2014-09-3039,467USD92
2014-04-01 to 2014-06-3039,469USD91
2014-01-01 to 2014-03-3139,468USD90
2013-10-01 to 2013-12-3139,468USD92
2013-07-01 to 2013-09-3039,468USD92
2013-04-01 to 2013-06-3058,268USD91
2013-01-01 to 2013-03-3187,781USD90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-349,134,225USD
At 2013-12-31-313,844,357USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-12-310USD365
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-31832,963USD
At 2013-12-31753,576USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-312,546,126USD365
2013-01-01 to 2013-12-313,880,058USD365
2012-01-01 to 2012-12-317,795,885USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-6,838,765USD92
2014-01-01 to 2014-12-31-34,954,552USD365
2014-07-01 to 2014-09-30-3,980,179USD92
2014-04-01 to 2014-06-30-16,437,522USD91
2014-01-01 to 2014-03-31-7,698,086USD90
2013-10-01 to 2013-12-31-11,984,290USD92
2013-01-01 to 2013-12-31-29,707,907USD365
2013-07-01 to 2013-09-30-6,257,907USD92
2013-04-01 to 2013-06-30-5,586,704USD91
2013-01-01 to 2013-03-31-5,879,006USD90
2012-01-01 to 2012-12-31-25,242,751USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-314,749,035USD
At 2013-12-312,849,424USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-31429,573USD365
2013-01-01 to 2013-12-311,437,584USD365
2012-01-01 to 2012-12-311,104,602USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-315,676,074USD
At 2013-12-3122,916,789USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-12-311,271,325USD
At 2013-12-312,285,331USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-12-3135,049,991USD365
2013-01-01 to 2013-12-3129,850,456USD365
2012-01-01 to 2012-12-3125,591,802USD366

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-3195,439USD365
2013-01-01 to 2013-12-31142,549USD365
2012-01-01 to 2012-12-31349,051USD366

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2014-01-01 to 2014-12-3162,436USD365
2013-01-01 to 2013-12-3182,436USD365
2012-01-01 to 2012-12-31117,436USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-3110,529,321USD365
2013-01-01 to 2013-12-3111,564,768USD365
2012-01-01 to 2012-12-3114,158,936USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3134,620,218shares
At 2013-12-3126,402,650shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-12-31346,364,060USD
At 2013-12-31325,297,736USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-311,965,567USD
At 2013-12-311,735,259USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-311,132,604USD
At 2013-12-31981,683USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-312,515,674USD
At 2013-12-313,545,713USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-12-31308,444USD
At 2013-12-31896,741USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-36,638,137USD365
2013-01-01 to 2013-12-31-33,387,195USD365
2012-01-01 to 2012-12-31-36,632,122USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-3111,052,123USD365
2013-01-01 to 2013-12-3112,057,067USD365
2012-01-01 to 2012-12-3111,432,866USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-12-31173,065USD365
2013-01-01 to 2013-12-3193,507USD365
2012-01-01 to 2012-12-3158,637USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-172,656USD365
2013-01-01 to 2013-12-31-867,065USD365
2012-01-01 to 2012-12-31-10,515,470USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-12-31205,607USD365
2013-01-01 to 2013-12-31-1,314,341USD365
2012-01-01 to 2012-12-31-9,341,364USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-12-318,182,968USD365
2013-01-01 to 2013-12-317,968,310USD365
2012-01-01 to 2012-12-312,021,705USD366

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2014-01-01 to 2014-12-31100,793USD365
2013-01-01 to 2013-12-31389,133USD365
2012-01-01 to 2012-12-310USD366

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2014-01-01 to 2014-12-310USD365
2013-01-01 to 2013-12-310USD365
2012-01-01 to 2012-12-310USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-12-3125,661,844USD365
2013-01-01 to 2013-12-3117,777,604USD365
2012-01-01 to 2012-12-312,941,102USD366

Inspect the source

Entity
Ocata Therapeutics, Inc. / CIK 0001140098
Captured
SEC response SHA-256
35ed5f9b7b65d6962e417af6d880d4a32b17c4db50d76618066bbdf10dcb4c40

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001140098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))